Nimbus Therapeutics raises $210 million in fundraising round
The Boston-based biotech will work on new "small molecule" drugs to combat cancer and other ailments.
Source: bostonglobe.com
Stay updated with breaking news from Jeb Keiper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Boston-based biotech will work on new "small molecule" drugs to combat cancer and other ailments.
BOSTON--(BUSINESS WIRE)--Nimbus Therapeutics, LLC (“Nimbus Therapeutics” or “Nimbus”), a clinical-stage company that designs and develops breakthrough m